Blogs
More from the blog
- All
- About us
- Campaigning
- Dementia info
- Fundraising
- Living with dementia
- Our scientists
- Our supporters
- Research
Devastating, uplifting, funny, sad – the spectrum of care as told by Shobna Gulati
We were delighted to welcome actress and broadcaster Shobna Gulati to a special event on 16 September to mark the launch of her memoir Remember me?.
Dementia understanding counts for everything in 2020
Dementia is becoming a particularly tragic storyline in the ongoing narrative of COVID-19.
For Mum: why I’m supporting the campaign for dementia research
Nine months after the devastating loss of his mum to Alzheimer’s, Paul wants to do everything he can to ensure dementia research continues to make progress.
Introducing our new Director of Research
Dr Susan Kohlhaas has joined Alzheimer’s Research UK as our new Director of Research.
A cautious return – UK DRI at Cardiff University
We caught up with Dr Meghan Larin, a postdoctoral researcher, and Emma Randall, a research assistant, in Prof Vincent Dion’s lab at the UK DRI at Cardiff University.
Seven highlights from the world’s largest dementia research conference
This year, the world’s largest dementia research conference – the Alzheimer’s Association International Conference (AAIC) – went virtual. Here are our top seven highlights from the week!
Can we really reduce the number of people living with dementia by 40%?
We know that if we can understand what increases the risk of developing dementia, governments and individuals can be better informed about how to reduce that risk.
Celebrating the successes of our dementia researchers
Times are challenging for everyone at the moment and our dementia researchers are no exception, so now more than ever it’s important to celebrate our scientists’ successes.
A cautious return – dementia researchers head back to the lab
Now, as governments across the UK begin to ease restrictions, labs are starting to re-open and research that your support helps to fund is restarting. However, this process is complex and looks different for every lab and region.
Behind the headlines: COVID-19 and dementia
There have been many stories in the media over the past few months about COVID-19 and dementia.
He will always be my Dad, no matter what memories Alzheimer’s disease stole from him
This Father’s Day I’ll be lacing up my trainers for Dad and dementia research, and here’s why.
Untangling frontotemporal dementia
Dementia is thought to affect around 850,000 people in the UK. Most people associate the condition with Alzheimer’s disease, the most common cause of dementia. But there are other diseases that can cause the symptoms of dementia – including frontotemporal dementia (FTD).
You’ll feel tickety-boo with Tikiboo!
Have you heard the news about the partnership between Alzheimer’s Research UK and Tikiboo?
I’m helping Alzheimer’s Research UK from home, and you can too.
With social fundraising no longer an option, my new working from home environment meant that I had to find a different way to help, and that was to learn more about dementia.
Hidden beauty, fascinating insights
Microscopic images reveal the hidden beauty around and within us. Dementia researchers get a unique view of the intricate but stunning workings of the brain. To showcase the fascinating insights being gained in dementia research, we ran our Science Image Competition again this year.
Alzheimer’s Research UK supports tracking COVID-19 symptoms with new app
The COVID-19 Symptom Tracker app, developed by King’s College London, is joining forces with the UK’s largest health-based charities. The aim is to reach people most at risk of COVID-19, including those with pre-existing health conditions such as dementia, diabetes, heart disease and those over the age of 70.
Fundraising during a national crisis
You may take comfort in knowing that previous generations have found innovative ways to raise money for charity in the face of international crisis.
Running alone but supporting dementia research together
It’s been great to hear supporters viewing the postponement of their event as an opportunity to use the time to raise even more money for dementia research and smash their fundraising targets. It’s brilliant to know our supporters are finding a way to continue to support our work in these extraordinary times.
A glimmer of hope for an Alzheimer’s drug? What’s new with DIAN-TU?
This latest data offers a glimmer of hope for gantenerumab. The decrease in protein levels has led the researchers and the pharmaceutical company Roche to now invite the participants to take part in an open-label extension.
Vascular dementia explained
Although Alzheimer’s is the leading cause of dementia, vascular dementia affects 150,000 people in the UK, accounting for one in five of all dementia cases.
Research finds a way – our virtual conference showed it is possible
We hatched a plan to make sure that this year’s conference went ahead, but safely in light of the current coronavirus outbreak. It led to a huge social media effort to recreate the conference virtually on Twitter.
Positive lifestyle changes to help reduce the risk of developing dementia
We’re thrilled to announce that we’re partnering with Alzheimer’s Research UK, one of the world’s leading dementia research charities dedicated to diagnosis, prevention, treatment and cure.
“It’s the highlight of my career so far – I called my mum as soon as I found out”
Amy Lloyd wins the 2020 award, which would ordinarily have been presented at our annual Research Conference that was due to take place in Wales this month.
COVID-19 – The dementia research field adapts
People with dementia are likely to be particularly vulnerable to this virus so it is especially important that they and those around them take what steps they can to avoid transmission.
COVID-19: A message for our supporters
We’re acutely aware of the impact the outbreak will be having on people with dementia and their families, exacerbating an already unprecedented situation. Our hearts go out to everyone in such circumstances.
